Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T05:51:34.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page has removed a detailed citation of a clinical trial related to Cabozantinib and Sunitinib, which included an erratum and additional references.
    Difference
    0.8%
    Check dated 2025-05-07T19:09:47.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.15.0 to v2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:48:25.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed study design information for a clinical trial on metastatic renal cell carcinoma and the addition of a new version number for the study. The principal investigator's name and affiliation have also been retained.
    Difference
    27%
    Check dated 2025-04-16T01:39:12.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T20:10:59.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T18:20:27.000Z thumbnail image

Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.